Does Sugammadex Administration Affect Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy: A...

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Postoperative nausea and vomiting (PONV) is a common complication after laparoscopic cholecystectomy.
• Neuromuscular antagonism agents play a role in PONV incidence.

Purpose of the Study:

• To evaluate the efficacy of sugammadex versus neostigmine in preventing PONV.
• To compare antiemetic consumption between sugammadex and neostigmine groups.

Main Methods:

• Eighty patients undergoing elective laparoscopic cholecystectomy were randomized.
• Patients received either sugammadex or neostigmine for neuromuscular antagonism.
• PONV incidence and antiemetic use were prospectively recorded.

Main Results:

• The incidence of nausea and vomiting was 60% with sugammadex and 77.5% with neostigmine within 24 hours.
• Lower nausea incidence and rescue antiemetic needs were observed with sugammadex across all intervals.
• No statistically significant differences were found between the sugammadex and neostigmine groups.

Conclusions:

• Sugammadex demonstrates a potential benefit in reducing PONV incidence and severity.
• The need for rescue antiemetics may be lower with sugammadex.
• Further research may be needed to establish statistically significant differences.